期刊文献+

阻塞性睡眠呼吸暂停综合征患者端粒长度的变化及意义 被引量:3

Alteration of telomere length of the peripheral white blood cells in patients with obstructive sleep apnea syndrome
下载PDF
导出
摘要 目的探讨阻塞性睡眠呼吸暂停综合征(OSAS)患者外周血白细胞端粒长度的变化及意义。方法 OSAS患者11例,健康对照组10例,提取外周血白细胞DNA,纯度检测合格后,用Q-PCR法检测端粒长度相对T/S比率。结果 OSAS组外周血白细胞端粒长度相对T/S比率较对照组小(P<0.05)。结论 OSAS患者外周血白细胞端粒长度的缩短可能与其发病机制有关,低氧血症和高碳酸血症加速了端粒的损耗和细胞的凋亡。 Objective To study the alteration of telomere length of the peripheral white blood cells in patients with obstructive sleep apnea syndrome(OSAS) and explore its significance.Methods The DNA was extracted from the peripheral white blood cells of 11 patients with OSAS and 10 normal subjects matched for age and gender,and the T/S ratio was measured by fluorescence quantitative PCR.Results The T/S ratio in the peripheral white blood cells of patients with OSAS was obviously lower than that of the normal subjects(P0.05).Conclusion The reduction in the telomere length in the peripheral blood cells suggests a possible relationship between OSAS pathogenesis and telomere length,and hypoxemia and hypercapnia make accelerate telomere shortening and promote cell apoptosis.
作者 林里 李涛平
出处 《南方医科大学学报》 CAS CSCD 北大核心 2011年第3期457-460,共4页 Journal of Southern Medical University
基金 国家自然科学基金(39971789) 广东省自然科学基金(04020458)~~
关键词 阻塞性睡眠呼吸暂停综合征 端粒 白细胞 obstructive sleep apnea syndrome telomere white blood cells
  • 相关文献

参考文献13

二级参考文献53

  • 1黄席珍.老年人阻塞性睡眠呼吸暂停综合征与高血压[J].中华老年医学杂志,2005,24(4):256-257. 被引量:45
  • 2Blackburn EH. Switching and signaling at the telomere. Cell, 2001 ; 106:661-673.
  • 3de Lange T. T-loops and the origin of telomeres. Nat Rev Mol Cell Biol, 2004; 5(4):323-329.
  • 4Leri A, Franco S, Zacheo A, et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 up regulation. EMBO, 2003 ; 22( 1 ) : 131-139.
  • 5Oh H, Wang SC, Prahash A, et al. Telomere attrition and Chk2 activation in human heart failure. PNAS, 2003; 100:5378-5383.
  • 6Obana N, Takagi S, Kinouchi Y, et al. Telomere Shortening of Peripheral Blood Mononuclear Ceils in Coronary Disease Patients with Metabolic Disorders. Int Med, 2003; 42:150-153.
  • 7Ogami M, Ikura Y, Ohsawa M, et al. Telomere Shortening in Human Coronary Artery Diseases. Arterioscler Thromb Vasc Biol, 2004; 24:546-550.
  • 8Brouilette SW, Moore JS, McMahon AD, et al. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary prevention Study: a nested case-control study. Lancet, 2007 ; 369 : 107-114.
  • 9Start JM, McGurn B, Harris SE, et al. Association between telomere length and heart disease in a narrow age cohort of older people. Exp Gerontol, 2007; 42:571-573.
  • 10Matthews C, Gorenne l, Scott S, et al. Vascular Smooth Muscle Cells Undergo Telomere-Based Senescence in Human Atherosclerosis-Effects of Telomerase and Oxidative Stress. Circ Res, 2006; 99: 156-164.

共引文献20

同被引文献14

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部